AI can predict when patients undergoing radiation treatment for head and neck cancer may lose significant weight or require a feeding tube, according to findings presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

The National Lipid Association has issued a position statement recommending the use of icosapent ethyl for treating patients with atherosclerotic CVD or type 2 diabetes, rooting its endorsement in the positive results of the REDUCE-IT study.

A new machine learning approach can predict the negative side effects of radiation treatment in patients with head and neck cancers. The findings, presented at the American Society for Radiation Oncology (ASTRO) annual meeting, can help select patients who might need a more tailored care approach.

A study published in the Annals of Internal Medicine Sept. 17 suggests daily aspirin could result in a net benefit for some people without established CVD, further muddying the debate over whether aspirin is an effective preventive tool for those without heart disease.

The incidence of CIED infection in the U.S. has been increasing for the past two decades, according to work published in JACC: Clinical Electrophysiology this month.

Just weeks after it fast-tracked dapagliflozin for the treatment of chronic kidney disease, the FDA announced it was granting Fast Track status to the drug for another indication: heart failure.

Patients who undergo partial breast radiation therapy after a lumpectomy are as satisfied with the outcome as those who undergo whole breast radiation therapy, according to findings presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

The American Society of Nuclear Cardiology, together with eight other nuclear medicine and cardiology societies, have published a consensus document outlining the best practices for imaging and diagnosing cardiac amyloidosis.